Evaluation of fluorescence intensity in head and neck cancer patients treated with photoimmunotherapy using near-infrared camera system
Not Applicable
- Conditions
- Patients with head and neck cancer who are scheduled to be treated with photoimmunotherapy are eligible.
- Registration Number
- JPRN-UMIN000052240
- Lead Sponsor
- ational Cancer Center Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1) The primary site of tumor is other than larynx, oropharynx, hypopharynx, nasopharynx, oral cavity, nasal sinus, or salivary gland. 2) The patient's physician determines that the patient is not suitable to participate in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Successful fluorescence intensity imaging
- Secondary Outcome Measures
Name Time Method Fluorescence intensity before and after light irradiation and during treatment, Localization in tumor before and after light irradiation and during treatment